• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-150 通过调控 SIRT2/JMJD2A 信号通路促进非小细胞肺癌细胞的增殖和迁移。

miR‑150 promotes the proliferation and migration of non‑small cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway.

机构信息

Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China.

出版信息

Oncol Rep. 2018 Aug;40(2):943-951. doi: 10.3892/or.2018.6487. Epub 2018 Jun 12.

DOI:10.3892/or.2018.6487
PMID:29901178
Abstract

Lung cancer (LC), as the most common cause of cancer‑related mortality worldwide, is characterized by difficulties in early detection, a high degree of malignancy, poor sensitivity to radiotherapy and chemotherapy, and a low 5‑year survival rate. MicroRNA (miRNA) is a class of small, non‑coding, endogenously expressed RNA that serves vital roles in RNA silencing and post‑transcriptional regulation of gene expression. Previous studies have shown that abnormal expression of miRNA is relevant to various malignant tumors, including lung cancer. In the present study, miR‑150 was found to be significantly upregulated in non‑small cell lung cancer (NSCLC) cells, which also exhibited downregulation of SIRT2. Through downregulation of miR‑150 and/or overexpression of SIRT2 in NSCLC cells (A549 and H1299), in vivo assays revealed that the suppression of miR‑150 and re‑expression of SIRT2 could inhibit NSCLC cell growth. Additionally, the present data demonstrated that miR‑150 regulated NSCLC cell viability and mobility through SIRT2/JMJD2A. Finally, it was demonstrated that silencing of miR‑150 led to inactivation of the AKT signaling pathway, which eventually inhibited the viability and mobility of NSCLC cells. This inhibitory effect of miR‑150 could be exacerbated by upregulation of SIRT2. In conclusion, our results demonstrated that miR‑150 plays an important role in the development of lung cancer by serving as an oncogene via the SIRT2/JMJD2A signaling pathway.

摘要

肺癌(LC)是全球癌症相关死亡的最常见原因,其特征为早期检测困难、恶性程度高、对放疗和化疗的敏感性差以及 5 年生存率低。微小 RNA(miRNA)是一类小的、非编码的、内源性表达的 RNA,在 RNA 沉默和基因表达的转录后调控中发挥重要作用。先前的研究表明,miRNA 的异常表达与包括肺癌在内的各种恶性肿瘤有关。在本研究中,发现 miR-150 在非小细胞肺癌(NSCLC)细胞中显著上调,同时 SIRT2 下调。通过下调 NSCLC 细胞(A549 和 H1299)中的 miR-150 和/或过表达 SIRT2,体内实验表明抑制 miR-150 和重新表达 SIRT2 可抑制 NSCLC 细胞生长。此外,本数据表明 miR-150 通过 SIRT2/JMJD2A 调节 NSCLC 细胞活力和迁移。最后,证明沉默 miR-150 导致 AKT 信号通路失活,最终抑制 NSCLC 细胞的活力和迁移。miR-150 的这种抑制作用可通过 SIRT2 的上调而加剧。总之,我们的研究结果表明,miR-150 通过 SIRT2/JMJD2A 信号通路作为癌基因在肺癌的发生发展中发挥重要作用。

相似文献

1
miR‑150 promotes the proliferation and migration of non‑small cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway.miR-150 通过调控 SIRT2/JMJD2A 信号通路促进非小细胞肺癌细胞的增殖和迁移。
Oncol Rep. 2018 Aug;40(2):943-951. doi: 10.3892/or.2018.6487. Epub 2018 Jun 12.
2
SIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2A.SIRT2通过靶向JMJD2A抑制非小细胞肺癌的生长。
Biol Chem. 2015 Aug;396(8):929-36. doi: 10.1515/hsz-2014-0284.
3
miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.微小RNA-125b通过PI3K/Akt/GSK3β信号通路调节人非小细胞肺癌的细胞凋亡。
Oncol Rep. 2017 Sep;38(3):1715-1723. doi: 10.3892/or.2017.5808. Epub 2017 Jul 12.
4
Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150.含Jumonji结构域蛋白2A通过微小RNA-150预测肺癌预后并调控细胞生长。
Oncol Rep. 2016 Jan;35(1):352-8. doi: 10.3892/or.2015.4349. Epub 2015 Oct 26.
5
Circular RNA circ‑ACACA regulates proliferation, migration and glycolysis in non‑small‑cell lung carcinoma via miR‑1183 and PI3K/PKB pathway.环状 RNA circ-ACACA 通过 miR-1183 和 PI3K/PKB 通路调控非小细胞肺癌细胞的增殖、迁移和糖酵解。
Int J Mol Med. 2020 Jun;45(6):1814-1824. doi: 10.3892/ijmm.2020.4549. Epub 2020 Mar 24.
6
Antitumor effects of hsa‑miR661‑3p on non‑small cell lung cancer in vivo and in vitro.hsa-miR661-3p 对体内外非小细胞肺癌的抗肿瘤作用。
Oncol Rep. 2019 May;41(5):2987-2996. doi: 10.3892/or.2019.7084. Epub 2019 Mar 21.
7
MicroRNA‑21 increases cell viability and suppresses cellular apoptosis in non‑small cell lung cancer by regulating the PI3K/Akt signaling pathway.MicroRNA-21 通过调控 PI3K/Akt 信号通路增加非小细胞肺癌细胞活力并抑制细胞凋亡。
Mol Med Rep. 2017 Nov;16(5):6506-6511. doi: 10.3892/mmr.2017.7440. Epub 2017 Sep 8.
8
MicroRNA-1197 downregulation inhibits proliferation and migration in human non- small cell lung cancer cells by upregulating HOXC11.MicroRNA-1197 下调通过上调 HOXC11 抑制人非小细胞肺癌细胞的增殖和迁移。
Biomed Pharmacother. 2019 Sep;117:109041. doi: 10.1016/j.biopha.2019.109041. Epub 2019 Jun 7.
9
Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.长链非编码 RNA LINC00460 通过海绵吸附 miR-769-5p 促进非小细胞肺癌对吉非替尼的耐药性。
DNA Cell Biol. 2019 Feb;38(2):176-183. doi: 10.1089/dna.2018.4462. Epub 2019 Jan 2.
10
Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.长链非编码 RNA PVT1 的敲低通过调节 miR-497 的表达抑制非小细胞肺癌的肿瘤发生。
Exp Cell Res. 2018 Jan 1;362(1):172-179. doi: 10.1016/j.yexcr.2017.11.014. Epub 2017 Nov 11.

引用本文的文献

1
Ga/Tb-CP2 as a Paired Radiopharmaceutical Targeting KDM4A and the Preliminary Verification in NCI-H2228 Xenografts Model.镓/铽-环戊二烯配合物2作为靶向赖氨酸特异性去甲基化酶4A的双标记放射性药物及其在NCI-H2228异种移植模型中的初步验证
ACS Omega. 2025 Jun 24;10(26):28286-28295. doi: 10.1021/acsomega.5c03248. eCollection 2025 Jul 8.
2
Tubulin Acetylation: A Critical Regulator of Microtubule Function.微管蛋白乙酰化:微管功能的关键调节因子
Results Probl Cell Differ. 2025;75:91-140. doi: 10.1007/978-3-031-91459-1_4.
3
Emerging role of sirtuins in non‑small cell lung cancer (Review).
沉默信息调节因子 2 相关酶 1 在非小细胞肺癌中的作用(综述)。
Oncol Rep. 2024 Oct;52(4). doi: 10.3892/or.2024.8786. Epub 2024 Aug 2.
4
MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review).微小 RNA 在肺腺癌中的调控作用:信号通路与潜在治疗意义(综述)。
Oncol Rep. 2023 Dec;50(6). doi: 10.3892/or.2023.8648. Epub 2023 Oct 20.
5
The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities.赖氨酸特异性去甲基化酶4A在癌症中的新作用:对肿瘤发生的影响及治疗机会
Genes Dis. 2023 Mar 23;11(2):645-663. doi: 10.1016/j.gendis.2022.12.020. eCollection 2024 Mar.
6
Phosphorylated nuclear DICER1 promotes open chromatin state and lineage plasticity of AT2 tumor cells in lung adenocarcinomas.磷酸化核 DICER1 促进肺腺癌中 AT2 肿瘤细胞的开放染色质状态和谱系可塑性。
Sci Adv. 2023 Jul 28;9(30):eadf6210. doi: 10.1126/sciadv.adf6210. Epub 2023 Jul 26.
7
Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature.脑转移与非小细胞肺癌的配对分析揭示了独特的 microRNA 特征。
Int J Mol Sci. 2022 Dec 22;24(1):193. doi: 10.3390/ijms24010193.
8
Association of sirtuins (SIRT1-7) with lung and intestinal diseases.SIRT 蛋白(SIRT1-7)与肺部和肠道疾病的关系。
Mol Cell Biochem. 2022 Nov;477(11):2539-2552. doi: 10.1007/s11010-022-04462-9. Epub 2022 May 20.
9
Circ-ITCH correlates with less advanced tumor features as well as prolonged survival, and it inhibits cells proliferation but promotes apoptosis in non-small cell lung cancer.环状 ITCH 与不太晚期的肿瘤特征以及更长的生存期相关,并且它在非小细胞肺癌中抑制细胞增殖但促进细胞凋亡。
Transl Cancer Res. 2019 Sep;8(5):1672-1679. doi: 10.21037/tcr.2019.08.01.
10
Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer.Epi - 微小RNA:人类癌症中组蛋白修饰机制的调节因子
J Oncol. 2022 Jan 11;2022:4889807. doi: 10.1155/2022/4889807. eCollection 2022.